$2,890.00

NCI-H929/RFP stable cell line

Catalog number
CL-2264
Description
NCI-H929/RFP cells are derived from the human B lymphocyte NCI-H929 cell line by stably integration of a constitutive RFP stably expression construct. NCI-H929 cells stably express B cell maturation antigen (BCMA)-a novel treatment target for multiple myeloma (MM), and have been widely used in cancer research and drug development. NCI-H929/RFP cells stably stably express RFP, can be used for in vitro assays and in vivo imaging.

Product Details

Package Size 2 x 10^6 cells
Parental cell line NCI-H929 cells
Transgenic gene RFP
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2025, FenicsBIO. All rights reserved.